GSTA4 and Alzheimer disease: In another study, the Nrf2-activating compound Ku-Gan ameliorated the skin lesions in a mouse model of recurrent AD, which mainly involved increased expression of the Nrf2 target Gsta4 (Ma et al., 2024).